ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EU for AZ' COPD maintenance therapy pharmatimes
December 15, 2020AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been approved in the EU for maintenance treatment in adults with moderate to severe chronic obstructive pulmonary disease (COPD).
Pharma Sources Insight July 2025
